Drugs / Tritanrix™ HepB/Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00436007 Background | Apr 2007 → Sep 2008 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix HepB/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00436007 ↗ |
| Modality | Vaccine | “GSK Biologicals' re-constituted diphtheria, tetanus, pertussis, hepatitis B vaccine (Tritanrix™ HepB) and Haemophilus influenzae type B vaccine (Hiberix™)” NCT00436007 ↗ |
| Route | Intramuscular | “The GSK 257049 and Tritanrix™ HepB/Hib vaccines were administered intramuscularly in the left and right antero-lateral thigh, respectively.” NCT00436007 ↗ |